Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer (Q65537337)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Breast Cancer |
clinical trial |
Statements
Prospective, Multicenter, Randomized, Independent-group, Open-label Phase II Study to Investigate the Efficacy, Safety and Tolerability of 4 Regimen With 3 Doses of ZK 219477 (16 and 12 mg/m2 Body Surface Area as 3-hour Infusion or 22 mg/m2 Body Surface Area as 30-minute or 3-hour Infusion) in Patients With Metastatic Breast Cancer (English)
0 references
December 2005
0 references
March 2008
0 references
82
0 references
18 year
0 references